Bone Biologics (BBLG) Return on Invested Capital (2016 - 2017)
Bone Biologics (BBLG) has disclosed Return on Invested Capital for 2 consecutive years, with 2.84% as the latest value for Q2 2017.
Bone Biologics (BBLG) has disclosed Return on Invested Capital for 2 consecutive years, with 2.84% as the latest value for Q2 2017.